Iovance Biotherapeutics Inc. buy Wells Fargo & Company
Start price
20.02.24
/
50%
€11.70
Target price
20.02.25
€20.35
Performance (%)
-52.82%
End price
21.02.25
€5.52
Summary
This prediction ended on 21.02.25 with a price of €5.52. The BUY prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc. performed very badly with a performance of -52.82%. Wells_Fargo___Compan has a follow-up prediction for Iovance Biotherapeutics Inc. where he still thinks Iovance Biotherapeutics Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | -18.929% | -18.929% | -79.157% |
| iShares Core DAX® | 1.061% | -0.453% | 35.608% |
| iShares Nasdaq 100 | 2.615% | 4.747% | 20.718% |
| iShares Nikkei 225® | 5.693% | 9.002% | 14.243% |
| iShares S&P 500 | 1.433% | 3.156% | 14.073% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at Wells Fargo & Company from $17.00 to $22.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.87
08.08.25
08.08.25
€12.01
08.08.26
08.08.26
10.47%
18:50
18:50
Stopped prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€7.97
30.05.23
30.05.23
€15.85
30.05.24
30.05.24
4.72%
31.05.24
31.05.24